Targeting miRNA-based medicines to cystic fibrosis airway epithelial cells using nanotechnology
Paul J McKiernan,2 Orla Cunninghamm,1,2 Catherine M Greenem,2 Sally-Ann Cryan1,31School of Pharmacy, Royal College of Surgeons in Ireland, 2Respiratory Research Division, Department of Medicine, Royal College of Surgeons in Ireland Education and Research Centre, Beaumont Hospital, 3Trinity Centre fo...
Guardado en:
Autores principales: | McKiernan PJ, Cunningham O, Greene CM, Cryan SA |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2013
|
Materias: | |
Acceso en línea: | https://doaj.org/article/3f93a17188f948a3965567322bd40b0d |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Airway inflammatory markers in individuals with cystic fibrosis and non-cystic fibrosis bronchiectasis
por: Bergin DA, et al.
Publicado: (2013) -
miR-224-5p and miR-545-5p Levels Relate to Exacerbations and Lung Function in a Pilot Study of X-Linked MicroRNA Expression in Cystic Fibrosis Monocytes
por: Paul J. McKiernan, et al.
Publicado: (2021) -
Ecological Succession of Polymicrobial Communities in the Cystic Fibrosis Airways
por: Rutvij A. Khanolkar, et al.
Publicado: (2020) -
L-ornithine derived polyamines in cystic fibrosis airways.
por: Hartmut Grasemann, et al.
Publicado: (2012) -
One versus Many: Polymicrobial Communities and the Cystic Fibrosis Airway
por: Fabrice Jean-Pierre, et al.
Publicado: (2021)